Revenue segments as reported by the company.

U.S. Healthcare Solutions

International Healthcare Solutions

Pharmaceutical Distribution Services

Other

Intersegment eliminations

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Distribution, selling, and administrative

Depreciation and amortization

Employee severance, litigation, and other

Goodwill impairment

Impairment of assets

Acquisition, integration, and restructuring expenses

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

AmerisourceBergen

AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, and long-term care and alternate site pharmacies. The Other segment focuses on global commercialization services and animal health, and includes AmerisourceBergen Consulting Services ABCS, World Courier, and MWI. The company was founded by in Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment focuses on the distribution of specialty, brand-name, and generic pharmaceuticals. The International Healthcare Solutions segment includes pharmaceutical wholesale, related operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

AmerisourceBergen's (ABC) CEO Steve Collis on Q1 2020 Results - Earnings Call Transcript

Shares of AmerisourceBergen (NYSE: ABC) were nearly unchanged after the company reported Q1 results.

AmerisourceBergen: Q1 Earnings Insights

AmerisourceBergen's (ABC) Q1 earnings benefit from higher revenues, segmental growth and strong fiscal 2020 outlook.

AmerisourceBergen (ABC) Q1 Earnings Beat, Revenues Miss

AmerisourceBergen (ABC) delivered earnings and revenue surprises of 5.39% and -0.25%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

AmerisourceBergen (ABC) Tops Q1 Earnings Estimates

Baxter

Edwards Lifesciences

Thermo Fisher Scientific

Despite the ongoing US-China trade war, solid growth in emerging markets is likely to have contributed to the performance of the players in the medical products space this earnings season.

Medical Products' Jan 30 Earnings Roster: TMO, EW & More

AmerisourceBergen's (ABC) Q1 earnings are likely to reflect the better-than-expected performance at Pharmaceutical Distribution and higher revenues.

What's in Store for AmerisourceBergen (ABC) in Q1 Earnings?

Let's see if AmerisourceBergen (ABC) stock is a good choice for value-oriented investors right now from multiple angles.

Can Value Investors Choose AmerisourceBergen (ABC) Stock?

American Airlines

ArcBest

Commercial Metals

Owens & Minor

The guidance to design a winning portfolio comes from brokers. Given their thorough know-how pertaining to the stock market, investors often look to be guided by broker advice.

5 Stocks That Look Impressive After Broker Rating Upgrades

Covenant Transportation Group

Nordstrom

M/I Homes

It is in the best interest of investors to seek advice from brokers, who are deemed to be experts in the field of investing.

5 Broker-Friendly Stocks in Focus Amid Middle East Tensions

AmerisourceBergen: Consolidation Ending Soon

Cardinal Health

CVS Health

Johnson & Johnson

McKesson

Rite Aid

Teva Pharmaceutical

Walgreens

Several companies might have to pay out $48 billion or more.

Multi-Billion Dollar Opioid Litigation Targets Drug Companies, Drugstores, and Maybe Doctors

These medication movers touch most of the prescriptions in the U.S. Are their stocks a buy?

Should You Own These 3 Healthcare Distributors?

DISH Network

Ford Motor Company

Fortive

General Mills

Lincoln National

Noble Energy

SBA Communications

One of the most frequently-used technical trading indicators is the simple moving average (SMA).

9 S&P 500 Stocks That Just Crossed Above Their 200-Day Moving Average

AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock?

AmerisourceBergen (ABC) Up 5% Since Last Earnings Report: Can It Continue?

Amneal Pharmaceuticals

Endo International

Mallinckrodt PLC

Shares of some manufacturers and distributors of opioid drugs decline on Tuesday following reports that a criminal probe has been initiated by federal prosecutors.

Fed Reportedly Opens Criminal Investigation on Opioid Makers

Pharmaceutical companies are in trouble over their role in fueling the opioid crisis facing the U.S.

Pharma Companies Shares Tank As Feds Investigate Opioid Crisis

Federal prosecutors have opened a criminal investigation into whether pharmaceutical companies intentionally allowed opioid painkillers to flood communities, the Wall Street Journal reported on Tuesday, citing people familiar with the matter.

Federal prosecutors open criminal probe of opioid makers, distributors: WSJ

Shares of the companies embroiled in opioid litigation fell in afternoon trading afterThe Wall Street Journal reported the federal government had opened a criminal investigation into some opioid makers and distributors, citing sources.

Shares of opioid makers and distributors drop on criminal probe

AmerisourceBergen Corp (ABC) CEO Steve Collis on Q4 2019 Results - Earnings Call Transcript

AmerisourceBergen's (ABC) Q4 earnings benefit from higher revenues, segmental growth and strong fiscal 2020 outlook.

AmerisourceBergen (ABC) Q4 Earnings & Revenues Beat Estimates

Abbott Labs

Penumbra

Varian Medical Systems

DENTSPLY SIRONA

Medical Products' Nov 7 Earnings Roster: ABC, CAH & More

AmerisourceBergen (ABC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Should You Buy AmerisourceBergen (ABC) Ahead of Earnings?

Understated earnings and cheap valuation give this company a higher chance of beating earnings in the short-term and outperforming the market in the long-term.

Earnings Distortion Makes AmerisourceBergen a Stock to Buy

The first federal trial on the opioid crisis in the United States has been scrapped, after the court agreed to a $260m (£200m) settlement by the country's three largest drug distributors.

US drug giants settle first federal opioids lawsuit for $260m

Four drug companies plan to announce settlements Monday ahead of a massive trial that would accuse them of helping to fuel the nation's crippling opioid crisis, according to a report.

News for AmerisourceBergen Stock (ABC)